Form 4 for CWK Cushman & Wakefield Ltd.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0000950170-23-006460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-03 | CWK | Soloway Brett | See Remarks | M - OptEx | $0.00 | +6,677 | 219.7K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-03 | M | A | 6,677 | $0.00 | 219,661.30 | D | — | — | (F1) Represents vesting of ordinary shares earned in respect of performance-based restricted stock units based on the achievement by the Issuer of certain performance targets for the 2020-2023 performance period pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan. The reporting person has elected to defer settlement of the award until the earlier of January 2025 or termination under the Cushman & Wakefield plc Deferred Compensation Plan. |